Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
Abstract | OBJECTIVES: DESIGN: Prospective randomized animal study. SETTING: Animal Research, University of Barcelona, Spain. SUBJECTS: Thirty female pigs. INTERVENTIONS: The animals were randomized to receive nebulized saline solution (CONTROL); nebulized amikacin every 6 hours; nebulized fosfomycin every 6 hours; IV meropenem alone every 8 hours; nebulized amikacin and fosfomycin every 6 hours; amikacin and fosfomycin every 6 hours, with IV meropenem every 8 hours. Nebulization was performed through a vibrating mesh nebulizer. The primary outcome was lung tissue bacterial concentration. Secondary outcomes were tracheal secretions P. aeruginosa concentration, clinical variables, lung histology, and development of meropenem resistance. MEASUREMENTS AND MAIN RESULTS: CONCLUSIONS: Our findings corroborate that amikacin and fosfomycin alone efficiently reduced P. aeruginosa in tracheal secretions, with negligible effects in pulmonary tissue. Combination of amikacin and fosfomycin with IV meropenem does not increase antipseudomonal pulmonary tissue activity, but it does reduce development of meropenem-resistant P. aeruginosa, in comparison with the sole use of IV meropenem. Our findings imply potential merits for preemptive use of nebulized antibiotics in order to reduce resistance to IV meropenem.
|
Authors | Gianluigi Li Bassi, Ana Motos, Laia Fernandez-Barat, Eli Aguilera Xiol, Chiara Chiurazzi, Tarek Senussi, Maria A Saco, Carla Fuster, Marco Carbonara, Joaquim Bobi, Rosanel Amaro, Francesca De Rosa, Talitha Comaru, Hua Yang, Otavio T Ranzani, Joan-Daniel Marti, Mariano Rinaudo, Oscar Comino Trinidad, Montserrat Rigol, Josep Bringué, Jose Ramirez, David P Nicolau, Paolo Pelosi, Massimo Antonelli, Francesco Blasi, Antonio Artigas, A Bruce Montgomery, Antoni Torres |
Journal | Critical care medicine
(Crit Care Med)
Vol. 47
Issue 6
Pg. e470-e477
(06 2019)
ISSN: 1530-0293 [Electronic] United States |
PMID | 30882478
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Fosfomycin
- Amikacin
- Meropenem
|
Topics |
- Administration, Inhalation
- Administration, Intravenous
- Amikacin
(administration & dosage, pharmacology)
- Animals
- Anti-Bacterial Agents
(administration & dosage, pharmacology)
- Bacterial Load
(drug effects)
- Bronchoalveolar Lavage Fluid
(microbiology)
- Disease Models, Animal
- Drug Resistance, Bacterial
- Drug Therapy, Combination
- Female
- Fosfomycin
(administration & dosage, pharmacology)
- Lung
(microbiology, pathology)
- Meropenem
(administration & dosage, pharmacology)
- Nebulizers and Vaporizers
- Pneumonia
(drug therapy, microbiology, pathology)
- Prospective Studies
- Pseudomonas Infections
(complications, drug therapy)
- Pseudomonas aeruginosa
(drug effects)
- Random Allocation
- Swine
- Trachea
(metabolism, microbiology)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|